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Abstract 
Invariant natural killer T (iNKT) cells are innate T cells with powerful immune regulatory functions that 
recognize glycolipid antigens presented by the CD1d protein. While iNKT-cell-activating glycolipids are 
currently being explored for their efficacy to improve immunotherapy against infectious diseases and 
cancer, little is known about the mechanisms that control CD1d antigen presentation and iNKT cell 
activation in vivo. CD1d molecules survey endocytic pathways to bind lipid antigens in MHC class II 
containing compartments (MIICs) before recycling to the plasma membrane. Autophagosomes intersect 
with MIICs and autophagy-related proteins are known to support antigen loading for increased CD4+ T 
cell immunity. Here, we report that mice with DC-specific deletion of the essential autophagy gene Atg5 
showed better CD1d-restricted glycolipid presentation in vivo. These effects led to enhanced iNKT cell 
cytokine production upon antigen recognition and lower bacterial loads during Sphingomonas 
paucimobilis infection. Enhanced iNKT cell activation was independent of receptor-mediated glycolipid 
uptake or costimulatory signals. Instead, loss of Atg5 in DCs impaired clathrin-dependent internalization 
of CD1d molecules via the adaptor protein complex 2 (AP2) and, thus, increased surface expression of 
stimulatory CD1d:glycolipid complexes. These findings indicate that the autophagic machinery assists in 
the recruitment of AP2 to CD1d molecules resulting in attenuated iNKT cell activation, in contrast to the 
supporting role of macroautophagy in CD4+ T cell stimulation. 
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Introduction  
 
Invariant natural killer T (iNKT) cells constitute a subset of T cells that expresses a semi-invariant TCRα 
chain (Vα24Jα18 in humans and Vα14Jα18 in mice) and recognize glycolipid antigens in the context 
of the MHC class I-related glycoprotein CD1d.1 Upon TCR ligation, iNKT cells rapidly secrete large 
amounts of cytokines, such as IFNG and IL4, and act as an amplification relay at the interface of innate 
and adaptive immunity.2 Due to their capacity to induce maturation of dendritic cells (DCs) for the 
initiation and maintenance of adaptive immune responses,3-5 iNKT cells are regarded as a „natural 
adjuvant“; and iNKT cell agonists such α-galactosylceramide (αGalCer) and its analogues are currently 
being investigated in clinical trials as part of improved vaccination strategies against infections and 
cancers.6 The mechanisms controlling lipid antigen loading onto CD1d molecules for iNKT cell 
activation are incompletely understood. After assembly in the endoplasmic reticulum, CD1 molecules 
follow the secretory pathway through the Golgi apparatus to the plasma membrane. Some CD1d 
molecules also associate with MHC class II molecules and the invariant chain, which directs CD1d 
complexes to endosomal compartments without first reaching the plasma membrane.7,8 After trafficking 
to the plasma membrane, CD1 molecules including CD1d are internalized in order to sample antigens in 
the endo/lysosomal system9 and, similar to MHC class II molecules,10 recycle to the cell surface and 
present bound antigens to iNKT cells. Macroautophagy is an evolutionary conserved mechanism that 
delivers cytoplasmic constituents and substrates for MHC class II presentation to lysosomes and late 
endosomes.11,12 Involvement of autophagy-facilitated transport is confirmed by studies using mice with 
DC-specific deletion of the essential autophagy gene Atg5 that showed impaired CD4+ T cell priming 
after herpes simplex virus infection.12 Furthermore, human Atg5-deficient macrophages showed 
inefficient MHC class II presentation of extracellular antigens and decreased CD4+ T cell stimulation.13 
The relevance of the autophagy machinery in lipid antigen loading within endosomal compartments has 
not received adequate attention. Here, we investigated its role in dendritic cell-mediated iNKT cell 
activation.  
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Results  
Loss of Atg5 increases the iNKT cell stimulatory capacity of dendritic cells 
To investigate whether macroautophagy regulates CD1d trafficking, we initially determined the 
colocalization of CD1d with the microtubule-associated protein 1A/1B light chain 3 (LC3), present both 
on autophagosomes and LC3-associated phagosomes.13,14 In sorted primary splenic DCs, LC3 and CD1d 
colocalized in steady state as determined by Pearson’s correlation coefficient analysis. Activation of DCs 
with the toll-like receptor 9 agonist CpG, which facilitates DC-mediated iNKT cell activation,15 
significantly increased this colocalization (Fig. 1A). To test whether absence of the essential 
macroautophagy gene Atg5 in DCs inhibits CD1d antigen presentation similar to MHC class II 
presentation,13,16,17 we generated mice with conditional deletion of Atg5 in DCs (Atg5f/f × CD11c-Cre, 
designated Cre+ Atg5f/f). FACS-sorted splenic DCs isolated from Cre+ Atg5f/f mice and Cre− Atg5f/f 
littermates were pulsed with different amounts of the prototypic iNKT agonist αGalCer and used to 
stimulate the iNKT cell hybridomas A.407 and FF13. Surprisingly, Atg5-deficient DCs were more potent 
in eliciting IL2 production by both iNKT cell lines (Fig. 1B, C). Conversely, induction of the autophagy 
machinery in wild type DCs by non-cytotoxic concentrations of the mTOR inhibitor rapamycin reduced 
IL2 production upon coculture with iNKT cells (Fig. 1D; Fig. S1). These data indicate that autophagy 
proteins in DCs may regulate iNKT cell responses. 
To determine the mechanism of Atg5-dependent regulation of iNKT cell activation, we first 
evaluated whether Cre+ Atg5f/f DCs differed from Cre− Atg5f/f DCs in their acquisition of lipid antigen. 
While the prototypic iNKT cell agonist αGalCer is taken up via both low density lipoprotein receptor 
(LDLR)-mediated and scavenger receptor-mediated pathways,18 the nominal antigen 
digalactosylceramide (GalαGalCer) and the Sphingomonas-derived glucuronylceramide (GSL-1) require 
selective uptake via the LDLR or the scavenger receptor SRA, respectively.18,19 The absence of Atg5 in 
primary DCs resulted in more efficient stimulation of iNKT cell hybridomas independently of the type of 
antigen uptake, as shown by stimulation with LDLR-targeted (GalαGalCer), SRA-targeted (GSL-1), and 
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SRA/LDLR-targeted (αGalCer) glycolipid antigens (Fig. 2A). These findings suggest that the increased 
iNKT cell stimulation by Atg5-deficient DCs did not involve a unique type of internalizing receptor.  
Our findings observed in primary DCs were unexpected and appeared to be in contrast with a 
recent study in which Atg7-deficient GM-CSF-differentiated bone marrow-derived DCs (BMDCs) did not 
differ from macroautophagy-competent BMDCs in eliciting cytokine production by iNKT cells.20 To 
investigate this discrepancy we generated BMDCs from Atg5-deficient mice and also found that they 
elicit IL2 production by iNKT cells following uptake of glycolipid antigens to the same level as BMDCs 
from wild type mice (Fig. S2). Since in vitro-derived BMDC cultures contain heterogeneous cell 
populations including macrophages, DCs and neutrophils,21,22 we additionally FACS-purified in vitro 
generated BMDCs for CD11c+/MHC class II+ cells which were subsequently loaded with increasing 
concentrations of αGalCer and co-incubated with iNKT cells. Increased IL2 production by iNKT cells 
were observed only in Cre+ Atg5f/f CD11c+/MHC class II+ BMDC cultures loaded with high αGalCer 
concentrations (10 µg/ml) (Fig. S3). Even CD11c+/MHC class II+ BMDCs contain different myeloid cell 
subsets including common monocyte precursor-derived macrophages which are inferior to common DC 
precursor antigen-presenting cells in their T cell priming and stimulatory capacity.22,23 We therefore 
continued to study DC-mediated iNKT cell activation using FACS-sorted primary splenic DCs. Next, we 
determined whether Atg5-deficient DCs differed from their Atg5-competent counterparts in providing 
costimulatory signals required for physiological iNKT cell activation, i.e. CD40 expression and IL12 
production.24 Cre+ Atg5f/f DCs exhibited similar CD40 levels as Cre− Atg5f/f DCs (Fig. 2B). Moreover, 
Atg5-deficiency did not affect the frequency of IL12-producing DCs or the total amount of IL12 secreted 
by DCs in response to CD40 ligation (Fig. 2C), in agreement with the reported unaltered expression levels 
of CD40 and CD86 as well as normal production of IL12p40, IL6 and TNF in Atg5-deficient DCs in the 
steady state.12 Thus, loss of Atg5 in DCs increases their capability for iNKT cell activation independently 
of receptor-mediated lipid targeting mechanisms and most costimulatory properties. 
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Increased CD1d surface expression in Atg5-deficient primary DCs 
We next investigated whether loss of Atg5 enhances the iNKT cell stimulatory capacity of DCs by 
affecting CD1d expression. We first determined CD1d surface expression levels in DCs compared to B 
cells derived from Cre+ Atg5f/f mice and their Cre− Atg5f/f littermates. Sorted CD11c+/MHC class II+ DCs 
and CD19+/MHC class II+ B cells were analyzed for CD1d expression (Fig. 3A). Atg5-deficient DCs 
showed significantly higher expression levels of surface CD1d protein (Fig. 3B), whereas no difference 
was observed for B cells which lacked Cre-expression and, thus, were autophagy-competent (Fig. S4A). 
To determine whether loss of Atg5 regulates CD1d expression in vivo, Cre+ Atg5f/f and Cre− Atg5f/f mice 
were injected withαGalCer and CD1d presentation was investigated using the monoclonal antibody 
L363 that specifically detects CD1d:αGalCer-complexes, but does not bind to CD1d molecules loaded 
with other antigens.25 Compared to autophagy-competent DCs, Atg5-deficient DCs showed increased 
expression levels of CD1d:glycolipid complexes (Fig. 3C). Levels of stimulatory CD1d:antigen 
complexes were similar for B cells in Cre+ Atg5f/f mice (Fig. 3C). In contrast to CD1d, the expression 
levels of CD11c and MHC class II remained unchanged in Cre+ Atg5f/f DCs (Fig. 3D).  
 
Loss of Atg5 impairs CD1d internalization but not CD1d recycling to the cell surface 
CD1d expression levels at the cell surface are largely determined by the rates of CD1d internalization and 
recycling through endosomal and lysosomal compartments.26,27 Therefore, we separately analyzed the 
rates of CD1d internalization and CD1d recycling to the cell surface in primary Atg5-deficient and wild 
type DCs. To evaluate the kinetics of CD1d internalization, we determined the remainder of previously 
biotin-labeled CD1d molecules at the cell surface by flow cytometry. To assess CD1d recycling rates, we 
quantified newly resurfaced CD1d molecules after the cell surface CD1d had been previously blocked 
with unconjugated anti-CD1d antibodies (Fig. 4A). CD1d internalization was significantly impaired (Fig. 
4B), whereas trafficking of intracellular CD1d molecules back to the cell surface remained unaffected in 
Cre+ Atg5f/f DCs (Fig. 4C). As expected, B cells derived from Cre+ Atg5f/f mice and Cre− Atg5f/f littermates 
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showed similar kinetics of CD1d turnover (Fig. 4B, C). Thus, loss of Atg5 in primary DCs impairs CD1d 
internalization, leading to increased CD1d surface expression levels and an enhanced capacity of Atg5-
deficient DCs to activate iNKT cells. 
 
Reduced endosomal recruitment of CD1d and its adaptor protein AP2 in Atg5-deficient primary 
DCs 
Internalization of murine CD1d (mCD1d), which contains a tyrosine-based endosomal-targeting motif in 
its cytoplasmic tail,28 follows a clathrin-dependent pathway that allows binding of mCD1d to adaptor 
protein complexes (AP). Murine CD1d molecules bind AP2, which is expressed at the plasma membrane 
and targets internalized CD1d molecules to endosomal compartments.29-31 During macroautophagy, LC3 
conjugation to the autophagosomal membrane promotes recruitment of specific substrates into 
autophagosomes via LC3 binding anchor proteins which function as selective autophagy receptors in the 
presence of LC3-interacting regions (LIRs).32,33 AP2 has previously been identified to contain a LIR motif 
within its α-subunit, and this LC3 binding by AP2 facilitates delivery of β-amyloid precursors for 
lysosomal degradation.34 To determine whether loss of autophagy proteins impairs trafficking of AP2 and 
CD1d to endosomal compartments in primary DCs, colocalization of both molecules with the early 
endosomal antigen-1 (EEA1) was evaluated by confocal microscopy (Fig. 4D). Colocalization of AP2 
and CD1d with EEA1 was significantly reduced in Atg5-deficient DCs as compared to Cre− Atg5f/f DCs 
(Fig. 4E). These data suggest that autophagy proteins assist in the recruitment of CD1d molecules into 
endosomal compartments and provide a mechanistic explanation as to how loss of autophagy proteins 
stabilizes the cell surface expression of CD1d:glycolipid complexes on DCs. 
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Autophagy proteins in DCs regulate iNKT cell responses to lipid immunization and microbial 
infection in vivo 
We investigated whether loss of Atg5 regulates iNKT cell activation and DC maturation uponαGalCer 
challenge in vivo. Frequencies of iNKT cells, DCs and B cells were comparable in Cre+ Atg5f/f and Cre− 
Atg5f/f mice at steady state (Fig. 5A, Fig. S4B).  
Downregulation of the T cell receptor precluded the evaluation of iNKT cell frequencies and activation 
markers 12 hours after αGalCer challenge.35 Therefore, we determined IFNG and IL4 serum levels after 
glycolipid challenge in vivo. Following αGalCer injection, Cre+ Atg5f/f mice showed substantially higher 
IL4 levels after 4 hours and IFNG levels after 12 hours, as compared to Cre− Atg5f/f mice (Fig. 5B). α
GalCer-mediated activation of iNKT cells leads to full DC maturation in vivo within 4 hours.3 The 
increased and prolonged iNKT cell activation observed in Cre+ Atg5f/f mice was associated with enhanced 
phenotypic DC maturation as indicated by increased expression levels of CD86 as well as CD40 12 hours 
after αGalCer challenge while costimulatory molecule expression in B cells remained similar in α
GalCer-treated Cre+ Atg5f/f and Cre− Atg5f/f mice (Fig. 5C, Fig. S5).  
We next investigated whether the enhanced iNKT cell stimulatory capacity of Atg5-deficient DCs 
as observed upon αGalCer-challenge conferred protection against infection with Sphingomonas. The 
gram-negative, lipopolysaccharide-free bacterium Sphingomonas paucimobilis (S. paucimobilis), 
associated with opportunistic and nosocomial infections in immunocompromised patients,36 is known to 
contain glycosphingolipids which stimulate iNKT cells through their TCR in a CD1d-specific manner.37-40 
Although the stimulatory potential of S. paucimobilis-derived glycosphingolipids is lower as compared to 
αGalCer, iNKT cell recognition of these natural microbial glycolipids induces proinflammatory cytokine 
production in vitro and in vivo.37,39,41 Upon infection with S. paucimobilis, Cre+ Atg5f/f mice exhibited 
significantly lower pathogen loads in spleens and lungs as compared to their Cre− Atg5f/f counterparts 
(Fig. 5D). Reduced pathogen loads were associated with increased serum levels of proinflammatory 
cytokines such as the IFNG-induced protein 10 (IP10) and TNF. Production of IFNG tended to be higher 
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in Cre+ Atg5f/f mice, whereas IL17 production was unchanged (Fig. 5D). Thus, autophagy proteins in DCs 
regulate surface expression of stimulatory CD1d:glycolipid complexes, shape iNKT cell activation and 
subsequent DC maturation in response toαGalCer and natural microbial glycolipids in vivo. 
 
Discussion 
The autophagic machinery enhances adaptive immunity by supporting antigen loading onto MHC class II 
molecules and is currently being explored for its potential to improve T cell responses upon vaccinations 
in order to establish long-lasting T cell memory.42-45 Autophagosomes can fuse with MHC class II 
containing compartments and deliver intracellular antigens for loading onto MHC class II and MHC class 
I molecules.44,46-48 In addition, autophagy regulates exogenous antigen processing through the LC3-
phosphatidylethanolamine-conjugation machinery during LC3 associated phagocytosis, a process which 
requires Atg5 and facilitates MHC class II loading.12-14,17 Both pathways support loading of vesicular 
antigens onto MHC molecules, leading to increased and more efficient CD4+ T cell responses. A fraction 
of CD1d proteins associates with MHC class II and invariant chain complexes which are sorted into late 
endosomal MIICs before trafficking to the cell surface7,8 However, in contrast to the supportive activity 
on MHC class II presentation, we found that autophagy proteins negatively regulate the presentation of 
lipid antigens by CD1d. Loss of Atg5 in DCs impaired CD1d internalization, leading to increased 
expression of stimulatory CD1d:glycolipid complexes and enhanced iNKT cell activation.  
Internalization of CD1 molecules from the plasma membrane is essential for their ability to 
sample antigens in the endocytic system.28,49 CD1d molecules are internalized in clathrin-coated pits via 
the interaction of AP2 and AP3 with tyrosine-based sorting motifs present in the cytoplasmic tails of 
CD1.50,51 Tian et al. identified a LIR motif within the α-subunit of AP2 (AP2A1), which was reported to 
mediate enhanced Alzheimer precursor protein internalization and degradation.34 Once this motif was 
mutated to alanine repeats, AP2A1 did not longer coimmunoprecipitate with LC3.34 In line with this 
identification of AP2 as an LC3-interacting protein,34 we found that loss of Atg5 impairs trafficking of 
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both AP2 and CD1d molecules into endosomal compartments. Altogether, these data indicate that 
internalization of CD1d occurs less efficiently if AP2 cannot be recruited via LC3, leading to increased 
surface expression of stimulatory CD1d:glycolipid complexes.  
Similar to CD1d, surface levels of classical MHC class I molecules were recently reported to be 
elevated due to decreased endocytosis and degradation.52 However, AP2 components were not 
significantly reduced in immunoprecipitates of classical MHC class I molecules derived from Atg5-
deficient cells compared to wild type counterparts. Instead, Atg5-deficiency compromised MHC class I 
association with the AP2-associated kinase 1 which can support AP2-independent, but clathrin-dependent 
endocytosis pathways.52-54 Furthermore, LIR motifs have also been described in clathrin itself.55 Thus, 
autophagy proteins appear to affect different clathrin-dependent pathways for the internalization and 
degradation of classical and non-classical MHC class I molecules, respectively. 
Loss of autophagy proteins was recently reported to exert a T cell-intrinsic role in regulating 
iNKT cell development.20,56 Mice with T lymphocyte-specific deletion of Atg5 or Atg7 show reduced 
progression of thymic iNKT cells through the cell cycle and lower frequencies of both thymic and 
peripheral iNKT cell populations due to increased apoptosis and impaired survival.20,56 Frequencies of 
thymic and peripheral iNKT cells were unchanged in Cre+ Atg5f/f mice supporting the notion that the 
reported deficit in iNKT cell differentiation is cell-autonomous. Our data indicate that while autophagy 
proteins regulate iNKT cell development via T cell-intrinsic effects, they attenuate peripheral iNKT 
activation through their function in DC-mediated antigen processing and presentation.  
In conclusion, our findings indicate that the autophagic machinery regulates iNKT cell responses 
through CD1d internalization. These data broaden the concept of Atg-mediated antigen presentation and 
indicate that autophagy-related proteins might not only enhance, as previously described with MHC class 
II-restricted presentation of peptide antigens, but also limit and tune the presentation of lipid antigens and 
the activation of innate T cells. Its function in tuning lipid antigen presentation could potentially limit the 
efficacy of vaccination strategies that include iNKT cell ligands as adjuvants and target macroautophagy 
for improved CD4+ T cell immunity.44,45 A clear and comprehensive concept of how the autophagy 
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machinery couples to antigen-presentation and lymphocyte activation appears to be required to predict the 
outcome of therapeutic interventions in this pathway to boost adaptive immunity. 
 
Materials and Methods 
Immunocytochemistry and colocalization assays 
For assessing colocalization between LC3/CD1d, CD1d/EEA1 or AP2/EEA1 in splenic DCs, C57BL/6-, 
Cre+ Atg5f/f- or Cre− Atg5f/f-derived splenocytes were MACS-sorted via magnetic CD11c microbeads 
(Miltenyi Biotech, 130-097-059) according to the manufacturer’s recommendation using an autoMACS 
Pro separator (Miltenyi Biotech, 130-092-545). MACS-purified CD11c+ cells were plated out in 0.01% 
poly-l-lysine (Sigma-Aldrich, P4707-50ML) in ddH2O pretreated 8-well glass chamber slides (Nunc Lab-
Tek, NUNC-177402) at 1×105/chamber. For assessing colocalization between LC3/CD1d, CD11c+ 
splenocytes were then either kept in R10 (RPMI-1640 (Life Technologies, 7001612) + 10% FCS (Sigma-
Aldrich, F2442-6X500ML) + 50 U/ml P/S (Life Technologies, 15070-063) only or R10 supplemented 
with 2 μg/ml of the B-class murine toll-like receptor 9 agonist CpG ODN 1826 (InvivoGen, tlrl-1826-5) 
for 5 hours at 37°C and 5% CO2. A cytospin was performed (3 min, 300 g), supernatants were carefully 
aspired and chambers were washed twice (200 μl/chamber) with cold phosphate buffered saline (PBS; 
Thermo Fisher Scientific, 10010023). Cells were fixed for 15 min at room temperature (RT) in 3% 
paraformaldehyde (PFA; Santa Cruz Biotechnology, sc-281692) in PBS followed by two washing steps 
with PBS (200 μl/chamber). For CD1d/EEA1 colocalization studies, cells were incubated with Fc 
receptor III/II blocking antibody, labeled for CD1d 30 min at 4°C, then incubated at 37°C for an 
additional hour in R10, before fixation. Cells were permeabilized for 5 min at RT in 200 μl of 0.1% 
Triton X-100 (Sigma-Aldrich, X100-500ML) in PBS followed by 30 min of blocking with 100 μl of 1% 
bovine serum albumin (Sigma-Aldrich, A9576-50ML) /10% normal goat serum (NGS; Sigma-Aldrich, 
G9023-5ML) in PBS at RT. Afterwards cells were incubated with primary antibodies (rabbit-anti-LC3, 
rat-anti-CD1d, goat anti-EEA1, mouse-anti-AP2) in 0.1% saponin (Sigma-Aldrich, 47036-50G-F) /10% 
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NGS in PBS for 1 hour at RT. Chambers were carefully washed twice with 0.1% saponin in PBS (200 μ
l/chamber) followed by a 45 min incubation with secondary antibodies in 0.1% saponin/10% NGS in PBS 
(Alexa488-conjugated or Alexa555-conjugated anti-rabbit, anti-rat, anti-goat, and anti-mouse). Cells were 
washed twice with PBS (200 μl/chamber), followed by incubation with 4',6-Diamidino-2-Phenylindole, 
Dihydrochloride (Thermo Fisher Scientific, D1306) for 2 min at RT. Washing steps as above were 
performed and slides were mounted with ProLong Gold antifade mountant (Thermo Fisher Scientific, 
P36930), let sit for 24 hours at RT in the dark and were then transferred to 4°C in the dark until further 
analysis. Pictures were acquired using a 63×, 1.4 NA oil immersion lens with an inverted confocal laser 
scanning microscope (Leica SP5-UV). To determine colocalization, Pearson’s correlation coefficient 
values were calculated using JACoP (Just Another Colocalization Plugin) in ImageJ software. A Pearson 
score >0.6 indicates a statistically relevant colocalization of the signals. 
 
Coculture assays with splenic DCs  
CD1d-mediated presentation of lipid antigens was measured using the murine Vα14+/Vβ8+ iNKT cell 
hybridomas A.407 and FF13. NKT cell hybridomas were cultured in hybridoma culture medium (RPMI-
1640 supplemented with 10% FCS, 50 U/ml P/S, 2 mM L-glutamine (Thermo Fisher Scientific, 
25030081) and non-essential amino acids (Thermo Fisher Scientific, 11140050) at 37°C and 5% CO2. 
For coculture assays Cre− Atg5f/f- and Cre+ Atg5f/f-derived splenocytes were purified for CD11c+ cells 
using magnetic microbeads according to the manufacturer’s recommendation. CD11c-enriched fractions 
were further purified through FAC-sorting using an ARIA III FCF (gated on live CD11c/I-Ab double-
positive cells). Purified splenic DCs were directly sorted in round-bottom 96-well tissue culture plates at 
3×104 cells/well and kept in R10 at 37°C and 5% CO2 for 45 min in order to settle. Afterwards, wells 
were either supplemented with increasing amounts of the glycolipid antigen αGalCer (0.01 - 10 μg/ml) 
or left untreated for 4 hours. Each condition was applied in triplicates. Wells were carefully washed 3× 
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with PBS (200 μl/well) and 5×104 NKT hybridoma cells (A.407 or FF13) in hybridoma culture medium 
were added to a final volume of 200 μl/well. Control wells containing antigen-presenting cells- and 
iNKT hybridoma cells-only (with or without addition of αGalCer) were included. Wells were incubated 
at 37°C and 5% CO2. After 24 hours cell culture supernatants were collected for analysis of IL2 
concentrations via ELISA. In some experiments titrated concentrations of indicated glycolipid antigens 
were used instead of αGalCer.18  
 
Coculture assays with BMDCs  
BMDCs were generated by culturing the bone marrow of Cre− Atg5f/f or Cre+ Atg5f/f mice in presence of 2 
ng/ml recombinant GM-CSF (Biolegend, 576306) in vitro. After 7 days, differentiated BMDCs were 
harvested, purified over a 14.5% Histodenz (Sigma-Aldrich, D2158-100G) gradient and pulsed with 
titrated amounts of lipid antigens for 4 hours at 37°C and 5% CO2. Cells were then washed, and 1×104 
BMDCs were used to stimulate 5×104 A.407 iNKT hybridoma cells in triplicate cultures in 96-well 
tissue culture plates. IL2 concentrations in 24 hours cell culture supernatant were determined by ELISA. 
In some experiments, BMDCs were further purified via FAC-sorting for CD11c+/ I-Ab + cells. 
 
Flow cytometry  
For surface expression analysis of CD40, CD1d, CD11c and I-Ab, Cre− Atg5f/f- and Cre+ Atg5f/f-derived 
splenocytes were purified for CD11c+ cells using magnetic microbeads according to the manufacturer’s 
recommendation. After Fc receptor block (22.4 μg/ml, 20 min, 4°C) and subsequent washing step, 
CD11c-enriched fractions were stained for 20 min with LIVE/DEAD fixable Aqua Dead stain kit 
(Thermo Fisher Scientific, L34957) in PBS at 4°C in the dark. The CD11c-depleted fractions were used 
for CD1d surface stainings of B cells (gated on CD19/I-Ab double-positive cells). Samples were washed 
twice in cold PBS followed by incubation with respective fluorochrome-labeled antibodies in FACS 
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buffer (1% bovine serum albumin/0.1% NaN3 (Sigma-Aldrich, S8032-500G) in PBS) for 25 min at 4°C 
in the dark. After 2 washing steps with cold PBS samples were resuspended in 50 μl of FACS buffer 
prior to sample acquisition using a BD FACSCanto-II. For IL12 intracellular cytokine staining (ICS) 
using a Fixation/Permeabilization Solution Kit (eBioscience, 88-8824-00), CD11c-enriched fractions 
were plated out at 5×105 cells/well in 48-well tissue culture plates and incubated for 12 hours in R10 
either supplemented with 15 μg/ml anti-CD40 or not at 37°C and 5% CO2. For flow cytometry analysis 
of IL12+ cells, samples were additionally treated with Brefeldin A (Sigma-Aldrich, B5936-200UL; used 
at 10 μg/ml) during the last 5 hours of incubation to block IL12 secretion. Cells were washed twice with 
PBS and stained for live cells and the surface molecules CD11c and I-Ab (see above). Fixation and 
permeabilization for subsequent ICS were carried out according to the manufacturers recommendations 
(Fixation/Permeabilization Solution Kit). Samples were acquired with a BD FACSCanto-II and all data 
were analyzed using FlowJo software (Tree Star Inc.). The same set up as the ICS experiments was 
carried out omitting the addition of Brefeldin A. In these instances, cell culture supernatants were 
collected after 12 hours for analysis of secreted IL12 via ELISA.  
 
iNKT cell detection  
iNKT cells were detected using αGalCer-loaded CD1d tetramers. Single-cell suspensions from spleens, 
livers, and thymi were pre-treated with Fc Block and 0.5 mg/ml avidin (Sigma-Aldrich, A9275-1MG) in 
FACS buffer for 10 min. After 2 washes, cells were incubated with CD1d/αGalCer tetramers at RT for 
15 min before addition of anti-CD3εand further staining for 30 minutes. Washed cells were then 
depleted of erythrocytes, fixed with BD FACS Lysing Solution (BD Biosciences, 349202), and acquired 
on a BD LSR II using FACSDiva software. Analysis was performed using the FlowJo software (Tree Star 
Inc.). 
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Determination of cytokine concentration  
IL2 concentration in coculture supernatants was measured using a Mouse IL2 Ready-SET-GO reagent kit 
(eBioscience, 88-7024-76). IL12 concentration in cell culture supernatants was measured using the 
Mabtech Mouse IL12/IL23 p40 ELISA development kit (Mabtech, 3451-1H-6). Serum concentrations of 
IFNG and IL4 were measured using the Mouse IFNG or Mouse IL4 Instant ELISA kit (eBioscience, 
BMS606INST and BMS613INST). All measurements were carried out according to the respective 
manufacturer’s recommendation.  
 
Mice 
8 to 12 weeks old C57BL/6 (Janvier), Atg5flox/flox,57 Tg(Itgax-cre,-EGFP)4097Ach designated CD11c-Cre   
(Jackson), were bred and housed in the University of Zurich animal facility in individually ventilated 
cages according to Swiss animal laws and institutional guidelines. Atg5flox/flox mice were crossed to 
CD11c-Cre mice to obtain CD11c-Cre × Atg5flox/flox mice (designated Cre+ Atg5f/f) on a C57BL/6 
background. Atg5flox/flox mice (designated Cre− Atg5f/f) were used as littermate controls. All animal 
protocols were approved by the cantonal veterinary office of the canton of Zurich, Switzerland (protocol 
25706-ZH209/2014) and the canton of Bern, Switzerland (protocols BE46/14, BE73/14). 
 
Genotyping 
Animal genotype was confirmed by PCR analysis on DNA from tail or ear biopsies by the use of the 
following primer pairs (5’-3’):  
Atg5flox/flox GAATATGAAGGCACACCCCTGAAATG 
Atg5flox/flox GTACTGCATAATGGTTTAACTCTTGC 
Atg5flox/flox ACAACGTCGAGCACAGCTGCGCAAGG 
Atg5flox/flox CAGGGAATGGTGTCTCCCAC 
CD11c-Cre GCGGTCTGGCAGTAAAAACTATC 
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CD11c-Cre GTGAAACAGCATTGCTGTCACTT 
CD11c-Cre CTAGGCCACAGAATTGAAAGATCT 
CD11c-Cre GTAGGTGGAAATTCTAGCATCATCC 
 
Mouse organ processing 
After mice were euthanized with CO2, spleens were removed, collected in cold PBS, dissected into small 
pieces and digested for 30 min at 37°C and 5% CO2 with Collagenase D (Sigma-Aldrich, 
000000011088866001; used at 0.4 mg/ml) and DNAse (Qiagen, 79254; used at μg/ml) in PBS. Digest 
was stopped with EDTA (Sigma-Aldrich, ED-500G; used at 10 mM) for 5 min at 37°C and 5% CO2. 
The digested tissue was passed through a 70-μm cell strainer (Fisher Scientific, 08-771-2) to obtain 
single cell solutions. After washing step with cold PBS a red blood cell lysis (2 min, RT) was performed 
using 1 ml/spleen ACK lysis buffer (Thermo Fisher Scientific, A1049201) followed by washing with cold 
PBS. Single cell solutions were kept on ice until further processing. 
 
CD1d internalization assay 
For assessing internalization of surface CD1d in splenic DCs and B cells respectively, Cre− Atg5f/f - and 
Cre+ Atg5f/f -derived splenocytes were purified for CD11c+ cells using magnetic microbeads according to 
the manufacturer’s recommendation. After Fc receptor block (22.4 μg/ml, 20 min, 4°C) and 
subsequent washing step, the CD11c-enriched fraction was incubated for 30 min on ice with a 
biotinylated-CD1d antibody. After extensive washing with ice cold PBS cells were fractionated into the 
following groups (1×105/group): 90 min on ice, 90, 60 and 30 min at 37°C, 5% CO2. To assess CD1d 
internalization in B cells, the negative fraction from the MACS purification was processed accordingly in 
parallel. After respective incubation time, cells were washed with ice cold PBS and incubated with PE-
labeled streptavidin, anti-CD11c (CD11c-enriched fraction for DC analysis) or anti-CD19 (CD11c-
depleted fraction for B cell analysis), anti-I-Ab and LIVE/DEAD fixable Aqua Dead stain kit for 20 min 
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on ice in the dark. Samples were fixed with 3% PFA in PBS and acquired with a BD FACSCanto-II. All 
data were analyzed using FlowJo software (Tree Star Inc.). To obtain % internalized CD1d values, the 
following equation was employed:   
% internalized CD1d = 100 − [൮
MFI
sample
MFI
90 min ice
൲ × 100] 
 
CD1d recycling assay 
CD11c-enriched or -depleted fractions of Cre− Atg5f/f- and Cre+ Atg5f/f-derived splenocytes (see 
internalization assay for details) were incubated with protein synthesis inhibitor cycloheximide (Sigma-
Aldrich, 01810-1G; used at 1 μg/ml) supplemented R10 (60 min at 37°C, 5% CO2). After extensive 
washing with ice cold PBS, cells were either incubated with unconjugated anti-CD1d antibody for 30 min 
(pre-blocked) or left untreated (non-blocked) on ice. After washing step, cells were divided into the 
following groups (1×105/group): 30 min on ice (pre-blocked), 30 min on ice (non-blocked), 30, 20, 10, 5 
min at 37°C, 5% CO2. After respective incubation times, cells were washed with ice cold PBS and 
incubated with PE-labeled anti-CD1d antibody (of the same clone used for pre-blocking), anti-CD11c 
(CD11c-enriched fraction for DC analysis) or anti-CD19 (CD11c-depleted fraction for B cell analysis), 
anti-I-Ab and LIVE/DEAD fixable Aqua Dead stain kit for 20 min on ice in the dark. A non-blocked 
sample was stained with PE-labeled isotype control instead of the PE-labeled anti-CD1d antibody. 
Samples were fixed with 3% PFA in PBS and acquired with a BD FACSCanto-II. All data were analyzed 
using FlowJo software (Tree Star Inc). To obtain % recycled CD1d values, the following equation was 
employed: 
% recycled CD1d = [ ሺMFI sample − MFI preblockedሻሺMFI unblocked AB − MFI unblocked isotypeሻ] × 100. 
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Lipid in vivo chase 
Cre− Atg5f/f and Cre+ Atg5f/f mice were either injected intraperitoneally (i.p.) with 200 μl PBS or α
GalCer (1 μg). Injection time points were chosen as such that animals could be sacrificed at the same 
time point. Blood for serum cytokine analysis was collected via cardiac puncture. Blood was utilized for 
serum cytokine analysis (IFNG, IL4). Spleens were processed as described above (see mouse organ 
processing). MFI of co-stimulatory molecules was analyzed on either Cre+ (Cre+ Atg5f/f) or Cre− (Cre− 
Atg5f/f) CD11c/I-Ab+ splenocytes. 
 
Infection with S. paucimobilis 
Mice were intravenously (i.v.) infected with 107 colony forming units (CFU) S. paucimobilis (ATCC, 
29873) and organs were harvested and weighed at 24 hours post infection. After smashing organs in 
sterile H2O using a tissue lyzer (Qiagen, 85300), tenfold serial dilutions were plated onto Muller-Hinton 
agar (Sigma-Aldrich, 70192) containing 200 μg /ml streptomycin (Sigma-Aldrich, S9137) and incubated 
for 48 hours at 30° C. Colonies were then counted and bacterial titers calculated as CFU per g tissue.  
  
Statistics 
Statistical significance was determined using the unpaired two-tailed T test and Mann-Whitney U test in 
Prism software (GraphPad Software Inc.). P < 0.05 was considered significant. 
 
Antibodies, streptavidin, tetramer and iNKT lipid agonists 
Unconjugated anti-murine CD40 (Bio X Cell, BE0016-2; clone: FGK4.5/ FGK45), unconjugated anti-
murine CD16/32 (Bio X Cell, CUS-HB-197; clone 2.4G2), PE-conjugated anti-murine CD1d 
(eBioscience, 12-0011-83; clone: 1B1), PE-conjugated rat IgG2bκeBioscience, 12-4031-83; 
, PE-conjugated anti-α-GalCer:CD1d-complex (eBioscience, 12-
2019-82; clone: L363), PE-conjugated anti-murine IL12/IL23 p40 (eBioscience, 12-7123-81; clone: 
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C17.8), PerCP-Cy5.5-conjugated anti-murine CD8 (eBioscience, 45-0081-82; clone: 53.6.7), 
unconjugated anti-murine CD1d (Biolegend, 123515; clone: 1B1), biotinylated anti-murine CD1d 
(Biolegend, 123506; clone: 1B1), Pacific Blue-conjugated anti-murine CD19 (Biolegend, 115523; clone: 
6D5), Pacific Blue-conjugated anti-murine CD4 (Biolegend, 100428; clone: GK1.5), PE-conjugated anti-
murine CD40 (Biolegend, 124610; clone: 3/23), PE-Cy7-conjugated anti-murine CD11c (Biolegend, 
117318; clone: N418), APC-conjugated anti-murine I-Ab (clone: Biolegend, 107614; M5/114.15.2), APC-
conjugated anti-murine CD3 (Biolegend, 100236; clone: 17A2), PE-conjugated streptavidin (Biolegend, 
405204), unconjugated anti-LC3  (MBL International Corporation, PM036), Alexa Fluor488-conjugated 
F(ab')2-goat anti-rabbit IgG (H+L) (Thermo Fisher Scientific, A-11070) or -donkey anti-goat IgG (H+L) 
(Thermo Fisher Scientific, A-11055) and Alexa Fluor555-conjugated F(ab')2-goat anti-rat (H+L) (Thermo 
Fisher Scientific, A-21434) or -rabbit anti-mouse IgG (H+L) (Thermo Fisher Scientific, A-21427), 
unconjugated anti-EEA1 (Antibodies-online, ABIN1439993), unconjugated anti-AP2 (BD Biosciences, 
610502; clone 8/Adaptin alpha), PE-conjugated αGalCer-loaded CD1d tetramer (ProImmune, E001-2A), 
αGalCer (Adipogen, AG-CN2-0013-M001), GSL-1 and GalαGalCer (Avanti Polar Lipids, Inc.) 
 
iNKT cell hybridoma lines  
The Vα14+/Vβ8+ iNKT cell hybridoma A.407 was generated by fusion of ex vivo CD1d tetramer-sorted 
iNKT cells with the murine thymoma BW5147 (S.F. unpublished data). The FF13 hybridoma was 
generated by fusion of Vα14 iNKT cells sorted from αGalCer-treated C57BL/6 mice with mouse 
BW5147 thymic lymphoma cells. 58  
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Abbreviations 
αGalCer α-galactosylceramide 
AP2 adaptor protein complex 2 
Atg autophagy related gene 
BMDC bone marrow-derived DC 
DC dendritic cell 
EEA1 early endosome antigen 1 
GalαGalCer digalactosylceramide 
GM-CSF granulocyte-macrophage colony-stimulating factor 
GSL-1  glucuronylceramide 
IFN interferon 
IL interleukin 
iNKT invariant natural killer T cell 
IP10 IFNG-inducible protein 10 
LC3 microtubule-associated protein 1A/1B light chain 3 
LDLR  low-density lipoprotein receptor 
LIR  LC3-interacting region 
MIIC MHC class II loading compartment 
MHC  major histocompatibility complex 
S. paucimobilis sphingomonas paucimobilis 
SRA scavenger receptor A 
TCR  T cell receptor 
TNF  tumor necrosis factor 
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Figure Legends 
Figure 1 
Loss of Atg5 increases the iNKT cell stimulatory capacity of dendritic cells. C57BL/6 derived splenic 
DCs were either incubated with 2 μg/ml CpG or left untreated. Original magnification with 63×, 1.4 
NA oil immersion lens. Scatter dot plot representation and quantification of colocalization between CD1d 
and LC3 (Pearson’s coefficient analysis). Each symbol represents one cell. Pooled data of 3 independent 
experiments are shown. Scale bar: 2.5 µm. Statistics: two-tailed Mann-Whitney U Test (A). FACS-sorted 
CD11c+/I-Ab+ splenic DCs derived from Cre− Atg5f/f or Cre+ Atg5f/f animals were pulsed with increasing 
concentrations of αGalCer or left untreated and subsequently cocultured with the iNKT hybridoma cell 
line A.407 (B) or FF13 (C) for 24 hours. IL2 concentration in cell culture supernatants was measured via 
ELISA. Pooled data and SEM of >3 independent experiments are shown. Each experiment contained at 
least 3 animals per group. Statistics: Unpaired two-tailed T test. C57BL/6 derived purified splenic DCs 
were treated with rapamycin (RAP; 12.5 μM; 4 hours), subsequently pulsed with αGalCer (1 μg/ml; 4 
hours) and cocultured with iNKT hybridoma cell line A.407 (24 hours). IL2 concentration in cell culture 
supernatants was measured via ELISA. Pooled data and SEM of 3 independent experiments is shown. 
Each experiment contained at least 3 animals per group. Statistics: Unpaired two-tailed T test (D). *** p ≤ 
0.001,** p≤ 0.01,* ≤ 0.05, ns p> 0.05. 
 
Figure 2 
Receptor-mediated uptake of glycolipid antigens and costimulatory properties remain unchanged 
in Cre+ Atg5f/f DCs. CD1d-presentation of indicated iNKT cell agonists by primary splenic DCs was 
assessed using activation of the iNKT hybridoma A.407 as in Fig. 1B (A). Splenic DCs derived from 
either Cre− Atg5f/f or Cre+ Atg5f/f animals were stained for CD40 surface expression. Pooled data and SEM 
of 3 independent experiments are shown. Each experiment contained at least 3 animals per group. 
Statistics: Unpaired two-tailed T test (B). Frequency of IL12-producing splenic DCs upon CD40 ligation. 
Purified splenic DCs were either incubated with anti-CD40 overnight or left untreated. IL12 production 
was measured via intracellular cytokine staining and by ELISA. Results of 3 independent experiments are 
shown. Each experiment contained at least 3 animals per group. Statistics: Unpaired two-tailed T test (C). 
*** p ≤ 0.001,** p≤ 0.01,* ≤ 0.05, ns p> 0.05. 
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Figure 3 
Increased CD1d surface expression in Cre+ Atg5f/f DCs. Flow cytometric analysis of CD1d surface 
levels on splenic DCs. Representative contour plots of splenic DCs or B cells and histograms showing 
CD1d surface expression (A). Quantification of CD1d surface expression on splenic DCs and B cells. 
Pooled data and SEM from >3 independent experiments are shown. Each experiment contained at least 2 
animals per group. Statistics: Unpaired two-tailed T test (B). CD1d:αGalCer-complex staining (L363 
clone) in splenic DCs or B cells 4 hours after i.p. application of either αGalCer or PBS. Pooled data and 
SEM from 2 independent experiments is shown. Statistics: Unpaired two-tailed T test (C). DC surface 
expression of CD11c or I-Ab. Pooled data and SEM from >3 independent experiments is shown. Each 
experiment contained at least 2 animals per group. Statistics: Unpaired two-tailed T test (D). *** p ≤ 
0.001,** p≤ 0.01,* ≤ 0.05, ns p> 0.05. 
 
Figure 4 
Impaired CD1d internalization in Cre+ Atg5f/f DCs. CD1d surface levels are determined by the rates of 
CD1d internalization and recycling through endosomal and lysosomal compartments (A). Internalization 
of surface CD1d on splenic DCs or splenic B cells was analyzed using a biotin-based flow cytometric 
endocytosis assay. Pooled data and SEM of at least 3 independent experiments are shown. Each 
experiment contained at least 2 animals per group. Statistics: Unpaired two-tailed T test (B). CD1d 
recycling in splenic DCs or splenic B cells was analyzed using a flow cytometry based recycling assay. 
Pooled data and SEM of at least 3 independent experiments are shown. Each experiment contained at 
least 2 animals per group. Statistics: Unpaired two-tailed T test (C). Colocalization study of AP2/EEA1 
and CD1d/EEA1 via confocal microscopy. Original magnification with 63×, 1.4 NA oil immersion lens. 
Representative photographs from 2 independent experiments per colocalization study are shown. Scale 
bar: 2.5 µm (D). Scatter dot plot representation and quantification of colocalization between AP2/EEA1 
and between CD1/EEA1 via Pearson’s coefficient. Each symbol represents one cell. Pooled data of 2 
independent experiments per colocalization study are shown. Statistics: Unpaired two-tailed T test (E). 
*** p ≤ 0.001,** p≤ 0.01,* ≤ 0.05, ns p> 0.05. 
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Figure 5 
Autophagy proteins in DCs regulate iNKT cell responses to lipid immunization and microbial 
infection in vivo. Frequencies of iNKT cells (thymus, spleen and liver) from naïve Cre− Atg5f/f and Cre+ 
Atg5f/f mice were quantified. Representative dot plots from at least two independent experiments are 
shown (A). Serum concentration kinetics of IL4 and IFNG upon glycolipid challenge in vivo measured 
via ELISA (B). Surface expression kinetics of CD86 and CD40 on splenic DCs. Each symbol represents 
one animal. Pooled data of at least 2 independent experiments are shown. Statistics: Unpaired two-tailed 
T test (C). Quantification of bacterial titers (CFU/ g tissue) in spleen and lung after in vivo infection of 
mice with S. paucimobilis. Each symbol represents one animal. One representative of two experiments 
with similar results is shown. Quantification of serum cytokines upon in vivo infection with S. 
paucimobilis. One representative of two experiments with similar results is shown. Statistics: two-tailed 
Mann-Whitney U Test (D). *** p ≤ 0.001,** p≤ 0.01,* ≤ 0.05, ns p> 0.05. 
 
 
 
 
 
 
 
 





